PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Adp-Ribosylation Factor 1 196 Target Disease Leukemia 162,805 1 0.00 -1.00 0.01 0.52
Adp-Ribosylation Factor 1 196 Target Target ADRP 537 2 0.01 -0.99 0.01 0.70
Adp-Ribosylation Factor 1 196 Target Target BTK 1,263 1 0.00 -1.00 0.01 0.65
Adp-Ribosylation Factor 1 196 Target Target EGF 27,487 1 0.00 -1.00 0.01 0.56
Adp-Ribosylation Factor 1 196 Target Disease Malaria 56,215 2 0.00 -0.99 0.01 0.56
Adp-Ribosylation Factor 1 196 Target Disease Hepatitis 163,842 2 0.00 -0.99 0.01 0.54
Adp-Ribosylation Factor 1 196 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.01 0.52
Adp-Ribosylation Factor 1 196 Target Disease Osteopetrosis 2,017 1 0.00 -1.00 0.01 0.63
AKT3 293 Target Target APOE 12,771 1 0.00 -1.00 0.00 0.57
Adp-Ribosylation Factor 1 196 Target Target BMX 185 1 0.01 -0.99 0.01 0.71
Adp-Ribosylation Factor 1 196 Target Disease Influenza 67,933 1 0.00 -1.00 0.01 0.54
Adp-Ribosylation Factor 1 196 Target Target ERK1 18,374 1 0.00 -1.00 0.01 0.57
Adp-Ribosylation Factor 1 196 Target Disease Osteoporosis 46,215 1 0.00 -1.00 0.01 0.55
AKT3 293 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Disease Glioblastoma 17,933 6 0.00 -0.99 0.02 0.61
AKT3 293 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.00 0.54
AKT3 293 Target Drug Doxorubicin 28,033 3 0.00 -0.99 0.01 0.58
AKT3 293 Target Disease Inflammation 252,734 6 0.00 -0.99 0.02 0.54
Adp-Ribosylation Factor 1 196 Target Disease Shock 134,031 1 0.00 -1.00 0.01 0.53
AKT3 293 Target Target ERK2 3,287 2 0.00 -1.00 0.01 0.63
AKT3 293 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -1.00 0.00 0.61
AKT3 293 Target Target CCL2 3,560 1 0.00 -1.00 0.00 0.61
Eotaxin 2,457 Target Target CXCL10 2,386 41 0.02 -0.98 0.02 0.72
Eotaxin 2,457 Target Disease Angioedema 3,997 2 0.00 -1.00 0.00 0.58
Eotaxin 2,457 Target Drug Doxycycline 9,324 2 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Ulcers 45,142 4 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Inflammatory Bowel Diseases 4,684 5 0.00 -1.00 0.00 0.61
Eotaxin 2,457 Target Target Cardiotrophin-1 351 1 0.00 -1.00 0.00 0.62
Eotaxin 2,457 Target Disease Seizures 66,465 1 0.00 -1.00 0.00 0.49
Eotaxin 2,457 Target Target Elastase 13,875 16 0.00 -1.00 0.01 0.61
Eotaxin 2,457 Target Drug Kaempferol 2,992 2 0.00 -1.00 0.00 0.59
Eotaxin 2,457 Target Disease Skin Rash 3,684 1 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Nephrotic Syndrome 14,681 2 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Ankylosing Spondylitis 9,665 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Target Crth2 Receptor 51 1 0.00 -0.99 0.02 0.65
Eotaxin 2,457 Target Target CD34 24,598 25 0.00 -0.99 0.01 0.61
Eotaxin 2,457 Target Disease Lung Cancer 91,416 7 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Target BDNF 11,163 4 0.00 -1.00 0.00 0.57
Eotaxin 2,457 Target Disease Proteinuria 28,803 3 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Bacterial Infections 14,248 4 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target Macrophage Metalloelastase 100 1 0.00 -0.99 0.01 0.64
Eotaxin 2,457 Target Disease Cerebral Edema 3,889 1 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target CCL8 197 13 0.02 -0.96 0.07 0.71
Eotaxin 2,457 Target Drug Doxorubicin 28,033 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Disease Arthritis 128,324 1 0.00 -1.00 0.00 0.52
AKT3 293 Target Disease Shock 134,031 3 0.00 -0.99 0.01 0.54
AKT3 293 Target Target ERK1 18,374 4 0.00 -0.99 0.01 0.60
AKT3 293 Target Target ETS1 539 1 0.00 -1.00 0.00 0.67
AKT3 293 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.69
AKT3 293 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.00 0.56
ADSF 11 Target Disease Seizures 66,465 1 0.00 -0.95 0.09 0.59
ADSF 11 Target Target D-Dimer 6,185 1 0.00 -0.95 0.09 0.65
Eotaxin 2,457 Target Disease Inflammation 252,734 1,048 0.04 -0.76 0.43 0.66
ADSF 11 Target Target Adiponectin 11,994 3 0.01 -0.85 0.27 0.66
Eotaxin 2,457 Target Disease Infertility 35,448 2 0.00 -1.00 0.00 0.52
Eotaxin 2,457 Target Disease Erythema 22,182 3 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Target CYR61 539 1 0.00 -1.00 0.00 0.61
Eotaxin 2,457 Target Target CCL21 808 4 0.00 -1.00 0.00 0.65
Eotaxin 2,457 Target Target CXCL2 750 4 0.00 -1.00 0.01 0.65
Eotaxin 2,457 Target Target CCL1 220 10 0.01 -0.98 0.05 0.70
Eotaxin 2,457 Target Disease Heart Disease 118,291 11 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Liver Disease 49,817 4 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Urticaria 10,717 4 0.00 -1.00 0.00 0.57
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
Eotaxin 2,457 Target Disease Shock 134,031 14 0.00 -1.00 0.01 0.54
Eotaxin 2,457 Target Target Phospholipase A2 13,400 4 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Target CD95 4,266 1 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Disease Malaria 56,215 2 0.00 -1.00 0.00 0.52
Cathepsin G 1,613 Target Target Collagenase 3 367 1 0.00 -1.00 0.00 0.63
Cathepsin G 1,613 Target Disease Neutropenia 25,934 8 0.00 -1.00 0.00 0.58
Cathepsin G 1,613 Target Disease Hepatitis 163,842 8 0.00 -1.00 0.00 0.53
Cathepsin G 1,613 Target Target Collagen 138,882 59 0.00 -0.98 0.04 0.59
Cathepsin G 1,613 Target Disease Keratitis 10,599 1 0.00 -1.00 0.00 0.54
Cathepsin G 1,613 Target Disease Cholesterol 182,390 7 0.00 -1.00 0.00 0.52
Cathepsin G 1,613 Target Disease Rheumatoid Arthritis 78,952 43 0.00 -0.99 0.03 0.59
Cathepsin G 1,613 Target Target Kallikrein-8 19 1 0.01 -0.97 0.05 0.68
Cathepsin G 1,613 Target Disease Sarcoidosis 19,176 1 0.00 -1.00 0.00 0.53
Cathepsin G 1,613 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -1.00 0.00 0.54
Cathepsin G 1,613 Target Disease Allergic Rhinitis 12,280 1 0.00 -1.00 0.00 0.54
Cathepsin G 1,613 Target Target APOE 12,771 5 0.00 -1.00 0.00 0.58
Cathepsin G 1,613 Target Disease Acute Coronary Syndromes 9,133 1 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Target Antithrombin 13,773 14 0.00 -1.00 0.01 0.62
Cathepsin G 1,613 Target Disease Celiac Disease 8,026 1 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.53
Cathepsin G 1,613 Target Target CINC-2- alpha 9 1 0.01 -0.94 0.11 0.69
Cathepsin G 1,613 Target Disease Leukemias 14,152 6 0.00 -1.00 0.00 0.59
Cathepsin G 1,613 Target Target Proteinase-Activated Receptor 1 133 2 0.00 -0.99 0.02 0.67
Cathepsin G 1,613 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.53
Cathepsin G 1,613 Target Disease Asthma 109,610 17 0.00 -0.99 0.01 0.56
Cathepsin G 1,613 Target Disease Breast Cancer 173,695 9 0.00 -1.00 0.01 0.53
Cathepsin G 1,613 Target Disease Leukemia 162,805 41 0.00 -0.99 0.03 0.57
Cathepsin G 1,613 Target Disease Pain 409,851 5 0.00 -1.00 0.00 0.49
Cathepsin G 1,613 Target Disease Psoriasis 26,882 6 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Target Retinoic Acid Receptor Alpha 1,068 6 0.00 -1.00 0.01 0.67
Cathepsin G 1,613 Target Target CLK1 62 1 0.00 -0.99 0.02 0.66
Cathepsin G 1,613 Target Target Urokinase-Type Plasminogen Activator 3,939 8 0.00 -1.00 0.00 0.64
Cathepsin G 1,613 Target Disease Sepsis 64,798 20 0.00 -0.99 0.01 0.58
Cathepsin G 1,613 Target Disease Myelodysplastic Syndrome 7,378 2 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Target Renin 43,456 28 0.00 -0.99 0.02 0.60
Cathepsin G 1,613 Target Disease Sickle Cell 17,551 1 0.00 -1.00 0.00 0.53